What is the typical CT pattern of hypersensitivity pneumonitis (HP) and its treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypersensitivity Pneumonitis CT Patterns and Treatment

The typical CT pattern of hypersensitivity pneumonitis (HP) includes diffusely distributed ground-glass opacities, mosaic attenuation, and small airway disease features such as ill-defined centrilobular nodules and air trapping, with different presentations depending on whether the disease is nonfibrotic or fibrotic. 1

Nonfibrotic HP CT Patterns

Typical Nonfibrotic HP Pattern

  • Diffusely distributed ground-glass opacities (GGO) and mosaic attenuation as features of lung infiltration 1
  • Ill-defined, small (<5 mm) centrilobular nodules on inspiratory images 1
  • Air trapping on expiratory CT images 1, 2
  • Craniocaudal distribution is typically diffuse, sometimes with relative basal sparing 1
  • Axial distribution is typically diffuse without central or peripheral predominance 1

Compatible with Nonfibrotic HP Pattern

  • Uniform and subtle ground-glass opacities 1
  • Airspace consolidation 1
  • Lung cysts 1
  • Diffuse distribution (variant: peribronchovascular) 1

Fibrotic HP CT Patterns

Typical Fibrotic HP Pattern

  • Coexisting lung fibrosis and signs of bronchiolar obstruction 1

  • Irregular fine or coarse reticulation with architectural distortion 1

  • Septal thickening with or without traction bronchiectasis in areas of GGO 1

  • "Three-density pattern" (also called "headcheese sign") - a highly specific pattern showing three different lung densities: 1

    • Ground-glass opacities
    • Lobules of decreased attenuation and vascularity
    • Normal-appearing lung
  • Fibrosis typically most severe in mid or mid and lower lung zones 1

  • Relative basal sparing, which helps differentiate from idiopathic pulmonary fibrosis 1, 3

  • No central or peripheral predominance of fibrosis on axial images 1

Indeterminate for HP Pattern

  • UIP pattern alone (honeycombing with subpleural and basal predominance) 1
  • Fibrotic nonspecific interstitial pneumonia (NSIP) 1
  • Organizing pneumonia 1

CT Acquisition Parameters for HP Diagnosis

  • Noncontrast examination 1
  • Volumetric acquisition with submillimetric collimation 1
  • Thin-section CT images (<1.5 mm) 1
  • Both inspiratory and expiratory acquisitions (expiratory to evaluate air trapping) 1
  • Recommended radiation dose: 1-3 mSv ("reduced" dose) 1

Diagnostic Considerations

  • CT findings alone are not sufficient to make a definitive diagnosis of HP, especially in fibrotic HP 1
  • Integration with exposure history and clinical information is essential 1
  • Multidisciplinary discussion (MDD) is recommended for definitive diagnosis 1
  • In chronic HP, CT may show findings that overlap with other interstitial lung diseases 2, 3
  • Severity of traction bronchiectasis on CT is a strong predictor of mortality in chronic HP 4

Common Pitfalls in CT Interpretation

  • Chronic HP may have findings identical to usual interstitial pneumonia, making differentiation difficult 3
  • Desquamative interstitial pneumonia cannot reliably be distinguished from acute/subacute HP on CT 3
  • Mosaic attenuation pattern in chronic HP may represent patchy interstitial lung disease rather than small airways disease 5
  • Quantitative CT analysis shows that low attenuation areas can be overestimated by visual assessment 5

Treatment Considerations

While the question asks about treatment, the provided evidence focuses primarily on diagnostic imaging patterns rather than treatment approaches. Based on general medical knowledge, treatment typically includes:

  • Avoidance of the causative antigen when identified 1
  • Corticosteroids for symptomatic disease, particularly in acute and subacute forms 1
  • Immunosuppressive agents may be considered in chronic, progressive disease 1
  • Lung transplantation may be considered in end-stage disease 1

The prognosis is significantly influenced by the extent of fibrosis, with the presence of traction bronchiectasis and honeycombing on HRCT being strong predictors of mortality 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.